19th Annual Report 2005-06
20th Annual Report 2006-07
21st Annual Report 2007-08
22nd Annual Report 2008-09
23rd Annual Report 2009-10
24th Annual Report 2010-11
25th Annual Report 2011-12
26th Annual Report 2012-13
27th Annual Report 2013-14
28th Annual Report 2014-15
29th Annual Report 2015-16
30th Annual Report 2016-17
31st Annual Report 2017-18
32nd Annual Report 2018-19
33rd Annual Report 2019-20
34th Annual Report 2020-21
35th Annual Report 2021-22
36th Annual Report 2022-23
37th Annual Report 2023-24
June 2012
September 2012
December 2012
March 2013
June 2013
September 2013
December 2013
March 2014
June 2014
September 2014
December 2014
March 2015
June 2015
September 2015
December 2015
March 2016
June 2016
September 2016
December 2016
March 2017
June 2017
September 2017
December 2017
March 2018
June 2018
September 2018
December 2018
March 2019
June 2019
September 2019
December 2019
March 2020
June 2020
September 2020
December 2020
March 2021
June 2021
September 2021
December 2021
March 2022
June 2022
September 2022
December 2022
March 2023
June 2023
September 2023
December 2023
March 2024
Code of Conduct of BODs and Senior Management Personnel
Code of Conduct
Code of Practices and Procedures for Fair Disclosure of UPSI
Composition of Board Committees
CSR Policy
Draft Appointment letter for Independent Directors
Familiarization Programmes Imparted to Independent Directors
Nomination and Remuneration Policy
Policy against Sexual Harassment.pdf
Policy for Determining the Material Subsidiary
Policy on Dealing with Related Party Transaction
Policy on Determining the Materiality of Events
Policy on Preservation of Documents
Risk Management Policy
Whistle Blower Policy
Composition of Board of Directors
Disclosure of related Party transactions 30-09-2019
Criteria for making payments to Non Executive Directors Policy
Disclosure on Related Party transactions
Profile of Directors
Statement of Shares transferred to IEPF
Shares for the F.Y 2013-2014 Eligible for transfer to IEPF account
Board Approved CSR Project FY 2021-22
Board Approved CSR Project FY 2022-23
Board Approved CSR Project FY 2023-24
Intimation under Regulation-30-KYC updation
Notice of NCLT convened Equity shareholders Meeting of Bal Pharma Limited
Notice of NCLT convened Secured Creditors Meeting of Bal Pharma Limited
Notice of NCLT convened Unsecured creditors meeting of Bal Pharma Limited
Notice of NCLT convened Unsecured creditors meeting of Golden Drugs Private Limited
Scrutinizers_Report_NCLT_2023
Scrutinizer Report 2014
Scrutinizer Report 2015
Scrutinizers Report 2016
Scrutinizers Report 2017
Scrutinizers Report 2018
Scrutinizers Report 2019
Scrutinizers Report 2020
Scrutinizers Report 2021
Scrutinizers Report 2022
Scrutinizers Report 2023
Scrutinizers Report 2024
Notice 2016
Notice 2017
Notice 2018
Notice 2019
Notice 2020
Notice 2021
Balance Clinic LLP Annual Results 2014-2015
Balance Clinic LLP Annual Results 2015-2016
Balance Clinic LLP Annual Results 2016-2017
Balance Clinic LLP Annual Results 2017-2018
Balance Clinic LLP Annual Results 2018-2019
Balance Clinic LLP Annual Results 2019-2020
Lifezen Healthcare Pvt Ltd Annual Results 2014-2015
Lifezen Healthcare Pvt Ltd Annual Results 2015-2016
Lifezen Healthcare Pvt Ltd Annual Results 2016-2017
Lifezen Healthcare Pvt Ltd Annual Results 2017-2018
Lifezen Healthcare Pvt Ltd Annual Results 2018-2019
Lifezen Healthcare Pvt Ltd Annual Results 2019-2020
Bal Research Foundation Annual Results 2015-16
Bal Research Foundation Annual Results 2016-17
Bal Research Foundation Annual Results 2017-18
Bal Research Foundation Annual Results 2018-19
Bal Research Foundation Annual Results 2019-20
Golden Drugs Pvt Ltd Annual Results 2017-18
Golden Drugs Pvt Ltd Annual Results 2018-19
Golden Drugs Pvt Ltd Annual Results 2019-20
Shareholding Pattern December 2018
BM Notice 11.01.2019
Shareholders list of Unpaid Dividend for F.Y 2007-08
AGM eVoting & Book Closure Notice 2015
Shareholding Pattern March 2015
Compliance Report on Corporate Governance
Shareholders List of Unpaid Dividend for F.Y 2008-09
Dividend UnPaid Share Holders List 2015-16
Share Holding Pattern for the year ended 31.03.2017
CORRIGENDUM to AGM NOTICE 2016-17
Advertisement in NewsPapersBoard meeting Notice 2018-19
Advertisement in NewsPapersQuarterly Financials 2018-19
Shareholding Pattern December 2015
Shareholding Pattern June 2014
Shareholding Pattern June 2015
Shareholding Pattern September 2014
Shareholding Pattern September 2015
BM Notice 29.05.2018
BM Notice 10.08.2018
BM Notice 14.11.2018
BM Notice 29.05.2019
BM Notice 14.11.2019
BM Notice 12.02.2020
BM Notice 08.08.2019
BM Notice Rescheduled 13.08.2019
BM Notice 29.06.2020
BM Notice Rescheduled 29.06.2020
BM Notice 29.07.2020
BM Notice 08.09.2020
BM Notice 28.10.2020
BM Notice 11.11.2020
BM Notice 11.02.2021
BM Notice 17.03.2021
BM Notice 29.06.2021
BM Notice 10.08.2021
BM Notice 11.11.2021
BM Notice 10.02.2022
BM Notice 09.03.2022
BM Notice 13.04.2022
BM Notice 30.05.2022
EGM Notice 14.11.2022
Voting Results & Scrutinizers report
ICRA Rating Letter-Bal Pharma Limited
ICRA Rating Letter-Bal Pharma Limited-2021
Secretarial Compliance Report 31.03.2022
Share Holding Pattern 31.03.2022
Shareholders list of unpaid dividend for F.Y-2017-2018
Credit Rating
Out Come of the Board Meeting-Approval for Amalgamation of Golden Drugs Pvt Ltd with Bal Pharma Ltd.
Annual Return 2019-2020
Annual Return 2020-2021
Annual Return 2021-2022
Annual Return 2022-2023
Outcome of the Board Meeting- Approval of Audited Financial Statements for the FY 2022-23
Postal Ballot Notice
List of Seven Years unpaid, unclaimed Dividend or Shares liable to be transferred to IEPF
IEPF Letter to Shareholders
Copyright © 2016 Bal Pharma Limited.
